GSK is one of the biggest names in its sector. Coming off an earnings drop I'm looking for this to bounce back off support back to its previous levels.
Pink line support at 34.75 will cut my position under 34.55 small losses with large upside potential.
Entered 5/21 $39 Calls @.40 will look to average down if needed but they have 100+ days in time. Feel free to...
Yes Brrr brr. Penguin says BRRRR!!
Gsk Dipping , sets up for the ultimate swing trade!
as traders, These are the types of Opportunities you should be Looking for.
Always look for the best setups, with the Highest % chance of profiting.
This is one of those, - A setup with High chance of profiting.
Penguin says Good buy! Lets reach All time highs for no...
In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer...
I previously posted a longterm stock position that I added to my portfolio. This was GSK (GlaxoSmithKline) which is trading at the lower levels of its range and has good growth potential but also a sturdy dividend yield of more than 5% each year.
This stock has seen some strong bullish momentum this week and has broken out of a consolidation structure. The...
I would have expected a bull run immediately but because of the flat formation now, there might be a one wave drop before the bull run. thanks for the support. This market to me is bullish.
GSK: GlaxoSmithKline (GSK)
2020-12-17 08:59:00
FDA approves GSK's BENLYSTA as the first medicine for adult patients with active lupus nephritis in the US
even without vaccine considiration, GSK is good business with price at multiyear bottom zone. Started in september trials on vaccine, later in oct progress would be more clear, still there are no factors for price go lower.
Put tight stop loss under 37.
Next support level is 35, so if 37 would be broken and retested - take short position.
GSK Stock is A bit Undervalued RIght now.. Institutions have price targets of 42~-48
back on the Covid-low-trendline .. I dont see much Downside as Compared to upside.
Dip below 35.99 ~ 35.70 range Twice , back up to 36.30 <---- 50+ cent gap ups.
With Covid vaccine News coming any day now - Its this could be the next play.
No matter which company has the...
see full chart at www.tradingview.com
GSK
Entry $39.70
Target 1 $42.45
Target 2 $45.50
Target 3 $48
stoploss 38.70
Why this play?
There are 4 general approaches to the Covid vaccine.
1.A "killed" coronavirus that will get recognized as foreign matter in the blood. (Sinovac/Dynavax)
2.Coronavirus proteins themselves, produced industrially in outside cell...
